[go: up one dir, main page]

CA3102497A1 - Compose d'acide gras a noyau ouvert ayant une activite anticancereuse - Google Patents

Compose d'acide gras a noyau ouvert ayant une activite anticancereuse Download PDF

Info

Publication number
CA3102497A1
CA3102497A1 CA3102497A CA3102497A CA3102497A1 CA 3102497 A1 CA3102497 A1 CA 3102497A1 CA 3102497 A CA3102497 A CA 3102497A CA 3102497 A CA3102497 A CA 3102497A CA 3102497 A1 CA3102497 A1 CA 3102497A1
Authority
CA
Canada
Prior art keywords
compound
cancer
protecting group
composition
isotopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3102497A
Other languages
English (en)
Inventor
Judith BOBBITT
Ahmed ZEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oceans Ltd
Original Assignee
Oceans Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oceans Ltd filed Critical Oceans Ltd
Priority to PCT/CA2021/051168 priority Critical patent/WO2022040788A1/fr
Publication of CA3102497A1 publication Critical patent/CA3102497A1/fr
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3102497A 2020-08-24 2020-12-11 Compose d'acide gras a noyau ouvert ayant une activite anticancereuse Pending CA3102497A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CA2021/051168 WO2022040788A1 (fr) 2020-08-24 2021-08-23 Dérivés de lactone et à cycle ouvert d'acides gras en c-18 trihydroxy insaturés et compositions pharmaceutiques de ceux-ci ayant une activité anticancéreuse

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063069269P 2020-08-24 2020-08-24
US63/069,269 2020-08-24

Publications (1)

Publication Number Publication Date
CA3102497A1 true CA3102497A1 (fr) 2022-02-24

Family

ID=80679478

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3102497A Pending CA3102497A1 (fr) 2020-08-24 2020-12-11 Compose d'acide gras a noyau ouvert ayant une activite anticancereuse

Country Status (1)

Country Link
CA (1) CA3102497A1 (fr)

Similar Documents

Publication Publication Date Title
US6747021B2 (en) Cryptophycin compound
US8835693B2 (en) Migrastatin analogs and uses thereof
JP2008273981A (ja) 癌の処置におけるマイグラスタチンアナログ
CA3013514A1 (fr) Pyrazoles 3,5-disubstitues utilisables comme inhibiteurs de kinase de point de controle 1 (chk1), ainsi que leurs preparations et leurs applications
US12435071B2 (en) Bryostatin compounds and methods of preparing the same
JP2021536492A (ja) イルジン類似体、それらの使用、およびそれらを合成する方法
EP4032890A1 (fr) Composé amide hétérocyclique, sel pharmaceutiquement acceptable de celui-ci, et son procédé de préparation et son utilisation
CN104327097B (zh) 雷帕霉素的三氮唑衍生物和用途
EP2199275B1 (fr) Inhibiteur de troubles ischémiques
KR20170129688A (ko) 인돌아세트산의 코어구조를 함유하는 화합물 및 그의 용도
CA3102497A1 (fr) Compose d'acide gras a noyau ouvert ayant une activite anticancereuse
FI105270B (fi) Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi
WO2022040788A1 (fr) Dérivés de lactone et à cycle ouvert d'acides gras en c-18 trihydroxy insaturés et compositions pharmaceutiques de ceux-ci ayant une activité anticancéreuse
CN114478561B (zh) 一种依帕司他石蒜碱偶联物及其制备方法和用途
US20150045404A1 (en) Schweinfurthin analogues
CN114539204B (zh) 己糖激酶抑制剂及其合成方法和应用
GB2494595A (en) Phenylbutyryl curcumin derivatives and uses for preparing anti-tumor drugs thereof
US7700783B2 (en) Synthesis of discodermolide and variants thereof
KR101881115B1 (ko) 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도
CN103450164A (zh) 格尔德霉素衍生物及其制备方法和用途
WO2013126664A1 (fr) Identification d'isomères nsc23925 pour inverser la résistance multiple aux médicaments dans des cancers humains
JP2005023048A (ja) 3−アシル−4−アルキル−5−ヒドロキシメチルテトロン酸誘導体及びこれを有効成分とする医薬
HK1206745B (en) Schweinfurthin analogues
KR20100047495A (ko) 신규 갈바닉산 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 다약제내성 억제용 약학적 조성물
JPH1025280A (ja) ニトロイミダゾール誘導体